Marja C.J.A. van Eggermond

1.1k citations

35 papers · 893 indexed · h-index 17

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immunodeficiency and Autoimmune Disorders
- Reproductive System and Pregnancy
Gastroenterology top 10%

Papers in

Immunology 25
- T-cell and B-cell Immunology 16
- Immune Cell Function and Interaction 13
- Immunotherapy and Immune Responses 9
- Immunodeficiency and Autoimmune Disorders 7
Immunology and Allergy 2

Co-authors: Peter J. van den Elsen Ad Peijnenburg Sam J. P. Gobin Tjadine M. Holling Rutger J. Wierda Martine J. Jager M. J. Giphart Kyounghee Lee
Journals: Human Immunology (6 papers)Immunogenetics (3 papers)The Journal of Immunology (3 papers)Molecular Immunology (2 papers)Biochemical Pharmacology (2 papers)
Partner nations: Netherlands United States Türkiye

In The Last Decade

Marja C.J.A. van Eggermond

35 papers receiving 881 citations

Peers

Countries citing papers authored by Marja C.J.A. van Eggermond

Since Specialization

Citations

This map shows the geographic impact of Marja C.J.A. van Eggermond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja C.J.A. van Eggermond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja C.J.A. van Eggermond more than expected).

Fields of papers citing papers by Marja C.J.A. van Eggermond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marja C.J.A. van Eggermond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja C.J.A. van Eggermond. The network helps show where Marja C.J.A. van Eggermond may publish in the future.

Co-authors

The 25 scholars most cited alongside Marja C.J.A. van Eggermond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marja C.J.A. van Eggermond Line = papers co-authored together Marja C.J.A. van Eggermond links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Utilizing epigenetic regulators to improve HSC-based lentiviral gene therapy Blood Advances ·Parisa Tajer, Emin Onur Karakaslar, Kirsten Canté-Barrett, Brigitta A. E. Naber, Sandra A. Vloemans, Marja C.J.A. van Eggermond, Marie‐Louise van der Hoorn, Erik B. van den Akker, Karin Pike‐Overzet, Frank J. T. Staal	2024	2
2	Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells? Journal of Neuroinflammation ·Claudia Sestito, John J. P. Brevé, Marja C.J.A. van Eggermond, Joep Killestein, Charlotte E. Teunissen, Joram van Rossum, Micha M.M. Wilhelmus, Benjamin Drukarch, Peter J. van den Elsen, Anne‐Marie van Dam	2017	14
3	Skewed Expression of the Genes Encoding Epigenetic Modifiers in High-Risk Uveal Melanoma Investigative Ophthalmology & Visual Science ·Nola S. Herlihy, Mehmet Doğrusöz, T. Huibertus van Essen, J. William Harbour, Pieter A. van der Velden, Marja C.J.A. van Eggermond, Geert W. Haasnoot, Peter J. van den Elsen, Martine J. Jager	2015	29
4	Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques Life Sciences ·Rutger J. Wierda, Inge M. Rietveld, Marja C.J.A. van Eggermond, Jeroen A.M. Beliën, Erik W. van Zwet, J. Lindeman, Peter J. van den Elsen	2014	56
5	Simvastatin reduces CCL2 expression in monocyte-derived cells by induction of a repressive CCL2 chromatin state Human Immunology ·Dalila Lucíola Zanette, Marja C.J.A. van Eggermond, Geert W. Haasnoot, Peter J. van den Elsen	2013	6
6	Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors Journal of Cellular and Molecular Medicine ·Rutger J. Wierda, Hedwich F. Kuipers, Marja C.J.A. van Eggermond, Anne Benard, Jan C. van Leeuwen, Silvia Carluccio, Sacha B. Geutskens, J. Wouter Jukema, Víctor E. Márquez, Paul H.A. Quax, Peter J. van den Elsen	2011	22
7	Epigenetic Control in Immune Function Advances in experimental medicine and biology ·Peter J. van den Elsen, Marja C.J.A. van Eggermond, Rutger J. Wierda	2011	6
8	Genetic and Epigenetic Control of the Major Histocompatibility Complex Class Ib Gene HLA‐G in Trophoblast Cell Lines Annals of the New York Academy of Sciences ·Tjadine M. Holling, Marloes W.T. Bergevoet, Rutger J. Wierda, Marja C.J.A. van Eggermond, Peter J. van den Elsen	2009	20
9	A Role for EZH2 in Silencing of IFN-γ Inducible MHC2TA Transcription in Uveal Melanoma The Journal of Immunology ·Tjadine M. Holling, Marloes W.T. Bergevoet, Louis Wilson, Marja C.J.A. van Eggermond, Erik van Schooten, Renske D.M. Steenbergen, Peter J.F. Snijders, Martine J. Jager, Peter J. van den Elsen	2007	52
10	Epigenetic silencing of MHC2TA transcription in cancer Biochemical Pharmacology ·Tjadine M. Holling, Marja C.J.A. van Eggermond, Martine J. Jager, Peter J. van den Elsen	2006	24
11	Constitutive and IFNγ-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region Molecular Immunology ·Nienke van der Stoep, Edwin Quinten, Gabrielle Alblas, Aurelie Plancke, Marja C.J.A. van Eggermond, Tjadine M. Holling, Peter J. van den Elsen	2006	11
12	T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome Human Immunology ·Barbara C. Godthelp, Marja C.J.A. van Eggermond, Maarten J. D. van Tol, Jaak M. Vossen, Peter J. van den Elsen	2000	13
13	Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene Immunogenetics ·Ad Peijnenburg, Marja C.J.A. van Eggermond, R. Van den Berg, x D zden Sanal, Jaak M. Vossen, Peter J. van den Elsen	1999	21
14	Shared regulatory elements in the promoters of MHC class I and class II genes Immunology Today ·Peter J. van den Elsen, Ad Peijnenburg, Marja C.J.A. van Eggermond, Sam J. P. Gobin	1998	89
15	T cell development in a major histocompatibility complex class II‐deficient patient European Journal of Immunology ·Marja C.J.A. van Eggermond, Ger T. Rijkers, Wietse Kuis, B.J.M. Zegers, Peter J. van den Elsen	1993	19
16	The MHC class II deficiency syndrome: Heterogeneity at the level of the response to 5-azadeoxycytidine Research in Immunology ·M. Lambert, Marja C.J.A. van Eggermond, Margriet E. M. Kraakman, Ruud K. B. Schuurman, Peter J. van den Elsen	1990	8
17	Unambiguous typing for HLA-DQ TA10 and 2B3 specificities using specific oligonucleotide probes Human Immunology ·Marcel Kenter, Jacqueline D.H. Anholts, Geziena M. Th. Schreuder, Marja C.J.A. van Eggermond, G.M. Ghyselen, J. J. van Rood, M. J. Giphart	1989	17
18	An HLA-DQ alpha allele identified at DNA and protein level is strongly associated with celiac disease Human Immunology ·Bart O. Roep, Ronald E. Bontrop, A. S. Peña, Marja C.J.A. van Eggermond, J. J. van Rood, M. J. Giphart	1988	40
19	RFLP of the HLA‐DQα region: a diallelic DXα polymorphism, not linked to DR and DQ specificities Tissue Antigens ·Marcel G.J. Tilanus, Marja C.J.A. van Eggermond, H. Fei, J. D‘Amaro, Geziena M. Th. Schreuder, M. J. Giphart	1987	5
20	HLA class II DNA analysis by RFLP reveals novel class II polymorphism Human Immunology ·Marcel G.J. Tilanus, Marja C.J.A. van Eggermond, M. van der Bijl, Bruno Morolli, Geziena M. Th. Schreuder, René R. P. de Vries, M. J. Giphart	1987	12

About Marja C.J.A. van Eggermond

Marja C.J.A. van Eggermond is a scholar working on Immunology, Immunology and Allergy, Hematology, Ophthalmology and Radiology, Nuclear Medicine and Imaging, having authored 35 papers that have together received 893 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (13 papers), Epigenetics and DNA Methylation (9 papers), Immunotherapy and Immune Responses (9 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Immunology (607 citations), Gastroenterology (33 citations), Oncology (129 citations), Cancer Research (65 citations) and Hematology (48 citations). Marja C.J.A. van Eggermond has collaborated with scholars based in Netherlands, United States and Türkiye. Frequent co-authors include Peter J. van den Elsen, Ad Peijnenburg, Sam J. P. Gobin, Tjadine M. Holling, Rutger J. Wierda, Martine J. Jager, M. J. Giphart, Kyounghee Lee, Koichi S. Kobayashi and Yuen-Joyce Liu. Their work appears in journals such as Human Immunology, Immunogenetics, The Journal of Immunology, Molecular Immunology and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact